Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Trending Topics

    business

    Expect to grow 25-28% in FY12: Panacea Biotec

    In an interview with CNBC-TV18, Rajesh Jain, Joint MD, Panacea Biotec says, the company’s earnings before interest, taxes, depreciation, and amortization (EBITDA) margins have grown considerably in Q4. He expects company to grow 25-28% in FY12.

    first published: May 13, 2011 05:00 pm

    LATEST VIDEOS

    Watch More →

    A collection of the most-viewed Moneycontrol videos.

    Watch and Follow our leading shows

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347